Research graph
References from Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives. Local targets link to admitted publications; unresolved targets remain external evidence.
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention
10.1158/1055-9965.epi-13-1057 · 2014 · External reference
Gastric cancer: global pattern of the disease and an overview of environmental risk factors
10.1016/j.bpg.2006.04.008 · 2006 · External reference
Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma
10.1200/jco.1984.2.11.1249 · 1984 · External reference
Prospective randomized trial of combined oncological therapy for gastric carcinoma
10.1002/1097-0142(197908)44:2<385::aid-cncr2820440203>3.0.co;2-8 · 1979 · External reference
A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group
10.1038/bjc.1989.350 · 1989 · External reference
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction
10.1056/nejmoa010187 · 2001 · External reference
Updated analysis of SWOG-directed intergroup study 0116: A phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection
10.1200/jco.2011.36.7136 · 2012 · External reference
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
10.1056/nejmoa055531 · 2006 · External reference
Gastric biomarkers: a global review
10.1186/s12957-016-0969-3 · 2016 · External reference
Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers
10.1017/erm.2013.16 · 2014 · External reference
Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review)
10.3892/ol.2015.2959 · 2015 · External reference
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial
10.1200/jco.2011.39.1953 · 2012 · External reference
Effects of adjuvant radiotherapy on completely resected gastric cancer: A radiation oncologist’s view of the ARTIST randomized phase III trial
10.1016/j.radonc.2015.08.009 · 2015 · External reference
Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses
2015 · External reference
Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer
10.1016/j.ijrobp.2007.11.040 · 2008 · External reference
Evaluation of dose coverage to target volume and normal tissue sparing in the adjuvant radiotherapy of gastric cancers: 3D-CRT compared with dynamic IMRT
10.2349/biij.6.3.e29 · 2010 · External reference
Clinical outcomes for gastric cancer following adjuvant chemoradiation utilizing intensity modulated versus three-dimensional conformal radiotherapy. de Mello RA, editor
10.1371/journal.pone.0082642 · 2014 · External reference
10.1007/s10120-015-0461-8
10.1007/s10120-015-0461-8 · External reference
Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center
10.1245/s10434-012-2822-4 · 2013 · External reference
Effect of intensity modulated radiotherapy combined with S-1-based chemotherapy in locally advanced gastric cancer patients
10.1159/000358164 · 2014 · External reference
Phase I study of postoperative radiotherapy combined with capecitabine for gastric cancer
10.3748/wjg.v20.i4.1067 · 2014 · External reference
The impact of overall radiotherapy treatment time and delay in initiation of radiotherapy on local control and distant metastases in gastric cancer
10.1186/1748-717x-9-81 · 2014 · External reference
Extended lymph-node dissection for gastric cancer
10.1056/nejm199903253401202 · 1999 · External reference
[Guide for external beam radiotherapy. Procedures 2007].
10.1016/j.canrad.2007.09.005 · 2007 · External reference
Gastric cancer staging with radiologic imaging modalities and UICC staging system
10.1159/000350881 · 2013 · External reference
Diagnosis and evaluation of gastric cancer by positron emission tomography
10.3748/wjg.v20.i16.4574 · 2014 · External reference
Detecting recurrence of gastric cancer: the value of FDG PET/CT
10.1007/s00261-008-9424-4 · 2009 · External reference
Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer
10.3748/wjg.v21.i19.5901 · 2015 · External reference
Role of radiotherapy and newer techniques in the treatment of GI cancers
10.1200/jco.2014.59.9787 · 2015 · External reference
Unresolved reference
External reference
10.3389/fonc.2014.00205
10.3389/fonc.2014.00205 · External reference
Radiotherapy planning using MRI
10.1088/0031-9155/60/22/r323 · 2015 · External reference
Les volumes–cibles de la radiothérapie des adénocarcinomes gastriques
10.1016/s1278-3218(01)00106-8 · 2001 · External reference
Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation
10.1016/s0360-3016(01)02646-3 · 2002 · External reference
10.1007/s10120-011-0041-5
10.1007/s10120-011-0041-5 · External reference
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial
10.1200/jco.2004.08.026 · 2004 · External reference
Extent of lymph node dissection for adenocarcinoma of the stomach
2015 · External reference
Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer
10.1200/jco.2009.26.9654 · 2010 · External reference
Cancer de l’estomac : doses et volumes-cibles
10.1016/j.canrad.2008.07.011 · 2008 · External reference
Radiothérapie des cancers de l’œsophage, du cardia et de l’estomac
10.1016/j.canrad.2016.07.039 · 2016 · External reference
Interobserver variation of clinical target volume delineation in gastric cancer
10.1016/j.ijrobp.2009.06.023 · 2010 · External reference
Radiation therapy oncology group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer
10.1016/j.ijrobp.2012.01.022 · 2012 · External reference
3D conformal radiotherapy for gastric cancer–results of a comparative planning study
10.1016/j.radonc.2005.01.006 · 2005 · External reference
IMRT for adjuvant radiation in gastric cancer: A preferred plan?
10.1016/j.ijrobp.2005.03.013 · 2005 · External reference
IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer
10.1016/j.radonc.2014.08.039 · 2014 · External reference
Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer
10.1002/cncr.25246 · 2010 · External reference
Comparison of dosiology between three dimensional conformal and intensity-modulated radiotherapies (5 and 7 fields) in gastric cancer post-surgery
10.1007/s11596-013-1193-9 · 2013 · External reference
Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a Dutch cohort study
10.1245/s10434-014-4032-8 · 2015 · External reference
Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery
10.1007/s00432-011-1085-y · 2012 · External reference
Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer
10.1016/j.ijrobp.2008.12.036 · 2009 · External reference
Adjuvant IMRT/XELOX radiochemotherapy improves long-term overall- and disease-free survival in advanced gastric cancer
10.1007/s00066-013-0309-2 · 2013 · External reference
A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection
10.1016/j.radonc.2012.08.024 · 2012 · External reference
Incorporating breath holding and image guidance in the adjuvant gastric cancer radiotherapy: a dosimetric study
10.1186/1748-717x-7-98 · 2012 · External reference
Unresolved reference
External reference
Proton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report
10.3109/0284186x.2014.912351 · 2014 · External reference
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid
10.1200/jco.1986.4.5.685 · 1986 · External reference
Postoperative chemoradiotherapy after surgical resection of gastric adenocarcinoma: can LV5FU2 reduce the toxic effects of the MacDonald regimen? A report on 23 patients
10.1016/s0399-8320(05)80688-8 · 2005 · External reference
Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection
10.1111/j.1743-7563.2010.01331.x · 2010 · External reference
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2
10.1200/jco.2009.25.8376 · 2010 · External reference
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
10.1016/s1470-2045(13)70021-4 · 2013 · External reference
Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen)
10.1007/s12032-010-9741-7 · 2011 · External reference
Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114)
10.1200/jco.2008.20.3745 · 2009 · External reference
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer
10.1007/s00280-010-1256-6 · 2010 · External reference
Trends in the surgical treatment of gastric adenocarcinoma
10.1245/s10434-013-3314-x · 2014 · External reference
Multicenter phase 2 study of peri-irradiation chemotherapy plus intensity modulated radiation therapy with concurrent weekly docetaxel for inoperable or medically unresectable nonmetastatic gastric cancer
10.1016/j.ijrobp.2017.03.032 · 2017 · External reference
Use of normal tissue complication probability models in the clinic
10.1016/j.ijrobp.2009.07.1754 · 2010 · External reference
Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer
10.1016/j.ijrobp.2006.09.012 · 2007 · External reference
10.1002/cncr.30692
10.1002/cncr.30692 · External reference
Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection
10.1016/j.ijrobp.2012.07.2378 · 2012 · External reference
10.1200/jco.2016.34.15_suppl.4000
10.1200/jco.2016.34.15_suppl.4000 · External reference
TOPGEAR: a randomized, phase III trial of perioperative ECF chemotherapy with or without preoperative chemoradiation for resectable gastric cancer: interim results from an international, intergroup trial of the AGITG, TROG, EORTC and CCTG
10.1245/s10434-017-5830-6 · 2017 · External reference
10.1200/jco.2017.35.15_suppl.4004
10.1200/jco.2017.35.15_suppl.4004 · External reference
